Mesenchymal Stem Cell Transfer Suppresses Airway Remodeling in a Toluene Diisocyanate-Induced Murine Asthma Model

PURPOSE: Severe asthma is characterized by high medication requirements to maintain good disease control or by persistent symptoms despite high medication use. The transfer of bone marrow-derived mesenchymal stem cells (BMDMSCs) to the injured lungs is a possible treatment for severe asthma. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shin-Hwa, Jang, An-Soo, Kwon, Ji-Hee, Park, Seong-Kyu, Won, Jong-Ho, Park, Choon-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121063/
https://www.ncbi.nlm.nih.gov/pubmed/21738887
http://dx.doi.org/10.4168/aair.2011.3.3.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121063/
https://www.ncbi.nlm.nih.gov/pubmed/21738887
http://dx.doi.org/10.4168/aair.2011.3.3.205

Ejemplares similares